跳至主要内容
临床试验/NCT02597140
NCT02597140已完成4 期

Pilot Study of Effect of Intravenous Lidocaine on Propofol Requirement During Monitored Anesthesia Care in Facial Plastic Surgery

Chung-Ang University Hosptial, Chung-Ang University College of Medicine1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2015年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
total propofol requirements

研究概览

简要总结

The purpose of this randomized pilot study is to evaluate the effect of intravenous lidocaine on propofol requirement during BIS (Bispectral index) guided MAC (monitored anesthesia care) in facial plastic surgery.

详细描述

Several studies reported the usefulness of intravenous lidocaine as a coadjuvant agent during general anesthesia. We thought that there would be an interaction between intravenous lidocaine and hypnotic agent requirement. However, there is no data regarding the effect of systemic lidocaine during MAC. We, thus, would like to perform a randomized, double-blinded pilot study to evaluate the effect of intravenous lidocaine on propofol requirement during BIS guided MAC in facial plastic surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists physical status classification 1 or 2 patients
  • aged 20-65 years who were undergoing elective facial plastic surgery under monitored anesthesia care

排除标准

  • unwillingness to participate in the study
  • adverse reaction to the drugs used in the study
  • use of medications that interfere in local anesthetic metabolism
  • history of liver disease or kidney failure
  • neurological or psychiatric disease
  • history of drug or alcohol abuse
  • chronic use of benzodiazepine

研究组 & 干预措施

Lidocaine group

Experimental

Patients will be received an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr.

干预措施: lidocaine (Drug)

Lidocaine group

Experimental

Patients will be received an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr.

干预措施: propofol (Drug)

Control group

Placebo Comparator

Patients will be received an intravenous bolus injection of 1.5 mg/kg normal saline followed by a continuous normal saline infusion of 2 mg/kg/hr.

干预措施: normal saline (Drug)

Control group

Placebo Comparator

Patients will be received an intravenous bolus injection of 1.5 mg/kg normal saline followed by a continuous normal saline infusion of 2 mg/kg/hr.

干预措施: propofol (Drug)

结局指标

主要结局

total propofol requirements

时间窗: during monitored anesthesia care

Patients' sedation depth will be monitored using a BIS monitor. Propofol will be administered using target controlled infusion (TCI) from targeting 60 to 80 of BIS. At the end of surgery, total propofol requirements will be examined and collected.

次要结局

  • postoperative pain(30 minutes, 2 hours, and 4 hours after surgery)

研究者

发起方
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chongwha Baek

Professor

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

研究点 (1)

Loading locations...

相似试验